Optimizing buprenorphine training during undergraduate medical education: Medical student feedback and attitudes
The American Journal on Addictions · 2023-07 · 32 (4) · 376-384
DOI: 10.1111/ajad.13395 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal on Addictions, online erschienen am 27.02.2023. Verfasst von Tabitha E H Moses und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Students, Medical, Education, Medical, Undergraduate, Buprenorphine, Opioid-Related Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse, Michigan Department of Health and Human Services.
Abstract (Originalsprache)
Background and Objectives Strong evidence supports efficacy of medications for opioid use disorder (MOUD), but stringent prescribing policies impair access. Many physicians report discomfort prescribing MOUD due to inadequate knowledge. Most medical students believe MOUD training should occur during undergraduate medical education (UME). As legislation surrounding buprenorphine prescribing shifts, it is timely to consider how best to incorporate MOUD training into UME.
Methods
At the start of 3rd year, all students ( n = 290) received a survey regarding experiences working with people with OUDs, and beliefs and knowledge regarding harm reduction and treatment. During orientation, students completed an 8‐h online MOUD training. Afterwards, students completed another survey, including questions about training perceptions.
Results
One‐third of students (32.8%) completed MOUD training and both surveys. Before training, 60.0% had not heard of the waiver, but 82.1% endorsed interest in prescribing buprenorphine. Despite mixed feelings about training content and delivery, 79.1% believed future classes should receive it. Most thought it should be integrated longitudinally throughout the curriculum rather than as separate online training. Conclusion and Scientific Significance Medical students want more MOUD education throughout their training; however, the 8‐h online training may be less‐than‐optimal. As this training is no longer required to prescribe buprenorphine, there is an opportunity to modify the content presented. There is an urgent need for physicians with the knowledge and willingness to treat patients with OUD. Introducing integrated training about MOUD should help future physicians feel confident in their knowledge to treat patients and comfortable applying for the waiver.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA.
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA.
ORCID-Profile: Tabitha E H Moses, Mark K Greenwald
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
- Michigan Department of Health and Human Services
Zitieren
APA
Moses, T. E. H., Waineo, E., Levine, D., & Greenwald, M. K. (2023). Optimizing buprenorphine training during undergraduate medical education: Medical student feedback and attitudes. The American Journal on Addictions, 32(4), 376-384. https://doi.org/10.1111/ajad.13395
Vancouver
Moses TEH, Waineo E, Levine D, Greenwald MK. Optimizing buprenorphine training during undergraduate medical education: Medical student feedback and attitudes. The American Journal on Addictions. 2023;32(4):376-384. doi:10.1111/ajad.13395
BibTeX
@article{Moses2023,
author = {Moses, Tabitha E H and Waineo, Eva and Levine, Diane and Greenwald, Mark K},
title = {Optimizing buprenorphine training during undergraduate medical education: Medical student feedback and attitudes},
journal = {The American Journal on Addictions},
year = {2023},
volume = {32},
number = {4},
pages = {376--384},
doi = {10.1111/ajad.13395}
}
EUVIMED